Dynamic MapReport

World News   USA   California   Bay Area   Emeryville   Business   Bio Tech (23)
Emeryville, Bio Tech Timeline Tuesday, May 1 Bookmark and Share     Author
Search Bay Area News Atlas:

Problems Cause Chiron To Miss Earnings  Chiron Corp. won't ship as many flu shots as it initially had hoped Chiron gets OK on flu shots  FDA had released three lots of Chiron's product Fluvirin Chiron shares head upward  Investors hope that Novartis will boost a $4.5 billion purchase offer that the biotechnology firm turned down $4.5B Offered to Finish Chiron Takeover  Novartis is offering $4.5 billion in cash for the remaining stake in Chiron to complete its takeover Chiron's earnings hit hard  The losses from the back-to-back failures of 2 flu vaccine manufacturing plants eroded profits Chiron Warns on Fewer Flu Vaccines
World News (13) World Bio Tech (28) USA (336) California (187) Bay Area (12) Bay Area Bio Tech (139) Emeryville (91) Business (41) Bio Tech (23)
2010 (1) 2005 (12) 2004 (7) 2003 (2) 2002 (1)
Bio Tech on Wikipedia Bio Tech on Web

Amyris (2)   Chiron (28)
Novartis picks chief to head Chiron uni  Swiss pharmaceutical giant named Dr. Joerg Reinhardt, 49, as the leader of the new division if its $5.1 billion acquisition Novartis to buy Chiron
Amyris IPO price holds steady


year 2010 Top ^

Sep.28
  Amyris Biotechnologies, an startup that uses genetically modified yeast to produce biofuel, sold shares for the first time on the Nasdaq, closing at $16.50


year 2005 Top ^

Nov.4
Nov.1
  Chiron's board accepted a $5.1 billion purchase offer from Swiss pharmaceutical giant Novartis AG

Oct.18
Oct.13
Sep.7
Sep.1
Jul.28
Jun.15
  Chiron will not produce as many flu vaccines as previously announced because of production delays
Jun.7 Drug panel divided on Chiron medicine  Chiron is holding out hope that regulators will approve its inhaled medicine to prevent lung transplant rejection Apr.28 Flu shot problem hurts Chiron's profit  1st-quarter results fell well short of analysts' expectations Mar.2 Regulators Lift Suspension on Chiron
  British regulators are enabling the company to begin reproducing flu drugs
Jan.26 Chiron's 2004 income falls dramatically  Chiron hobbled by its failure to deliver half the nation's flu vaccine last year. It missed analysts' expectations

year 2004 Top ^

Oct.20 Flu Vaccine Fiasco Costs Chiron Millions
  Vaccine fiasco will cost the company $91 million Oct.15 Board member quits embattled Chiron  The company announced the resignation of Richard Wills, chief executive of Tektronix, in a one-sentence press release Oct.13 SEC probes Chiron over flu shot shortage  The commission has launched an inquiry into how Chiron handled the disclosure of vaccine-manufacturing problems Oct.5 Flu maker Chiron slashes profit outlook
  Chiron cut its profit forecast by more than half after British officials pulled the company's license
Aug.20 Chiron gets temporary restraining order  A biotechnology company succeeded in getting a restraining order against an animal rights group Jul.8 Chiron fined for trading with Cuba  Biotechnology company paid the U.S. government $168,500 in civil penalties Feb.27 Chiron sues animal activists  Chiron is accusing the activists of waging a violent harassment campaign and supporting the man charged with bombing

year 2003 Top ^

Dec.16 Chiron sells 375,000 additional flu vaccine  U.S. Health Secretary Thompson has announced the purchase from pharmaceutical company Mar.20 Chiron names new chief executive  Biotechnology company appointed former GlaxoSmithKline Plc executive Howard Pien its new CEO and president

year 2002 Top ^

Sep.7 Big patent win vs. Chiron
  Genentech: Chiron of Emeryville has no claim to any profits from Genentech's blockbuster breast cancer drug, Herceptin




Add a favorite (file a bookmark) to Emeryville, Bio Tech Timeline


Please send feedback to: support@mapreport.com

Advertise on Emeryville, Bio Tech Page

XML



Chiron sues animal activists  Chiron is accusing the activists of waging a violent harassment campaign and supporting the man charged with bombing Big patent win vs. Chiron  Genentech: Chiron of Emeryville has no claim to any profits from Genentech's blockbuster breast cancer drug, Herceptin Novartis to buy Chiron




Emeryville, Bio Tech Business Lawsuit Timeline ... See Bay Area Business Lawsuit timeline, World Business Lawsuit timeline Top ^
2004
Feb.27
2002
Sep.7




Emeryville, Bio Tech Merger and Acquisition Timeline ... See Bay Area Merger and Acquisition timeline, World Merger and Acquisition timeline Top ^
2005
Nov.1
  Chiron's board accepted a $5.1 billion purchase offer from Swiss pharmaceutical giant Novartis AG
Sep.1 $4.5B Offered to Finish Chiron Takeover  Novartis is offering $4.5 billion in cash for the remaining stake in Chiron to complete its takeover



Emeryville, Bio Tech Bio Tech Timeline ... See Bay Area Bio Tech timeline, World Bio Tech timeline Top ^
2005 Oct.13 Chiron gets OK on flu shots
  FDA had released three lots of Chiron's product Fluvirin Jul.28 Chiron's earnings hit hard  The losses from the back-to-back failures of 2 flu vaccine manufacturing plants eroded profits Jun.15 Chiron Warns on Fewer Flu Vaccines
  Chiron will not produce as many flu vaccines as previously announced because of production delays
Jun.7 Drug panel divided on Chiron medicine  Chiron is holding out hope that regulators will approve its inhaled medicine to prevent lung transplant rejection Apr.28 Flu shot problem hurts Chiron's profit  1st-quarter results fell well short of analysts' expectations Mar.2 Regulators Lift Suspension on Chiron
  British regulators are enabling the company to begin reproducing flu drugs
Jan.26 Chiron's 2004 income falls dramatically  Chiron hobbled by its failure to deliver half the nation's flu vaccine last year. It missed analysts' expectations 2004 Oct.20 Flu Vaccine Fiasco Costs Chiron Millions  Vaccine fiasco will cost the company $91 million Oct.13 SEC probes Chiron over flu shot shortage  The commission has launched an inquiry into how Chiron handled the disclosure of vaccine-manufacturing problems Oct.5 Flu maker Chiron slashes profit outlook
  Chiron cut its profit forecast by more than half after British officials pulled the company's license
Aug.20 Chiron gets temporary restraining order  A biotechnology company succeeded in getting a restraining order against an animal rights group Jul.8 Chiron fined for trading with Cuba  Biotechnology company paid the U.S. government $168,500 in civil penalties



Emeryville, Bio Tech Business Leaders Timeline ... See Bay Area Business Leaders timeline, World Business Leaders timeline Top ^
2005 Nov.4 Novartis picks chief to head Chiron uni  Swiss pharmaceutical giant named Dr. Joerg Reinhardt, 49, as the leader of the new division if its $5.1 billion acquisition 2004 Oct.15 Board member quits embattled Chiron  The company announced the resignation of Richard Wills, chief executive of Tektronix, in a one-sentence press release 2003 Mar.20 Chiron names new chief executive  Biotechnology company appointed former GlaxoSmithKline Plc executive Howard Pien its new CEO and president



Emeryville, Bio Tech Healthcare Business Timeline ... See Bay Area Healthcare Business timeline, World Healthcare Business timeline Top ^
2003 Dec.16 Chiron sells 375,000 additional flu vaccine  U.S. Health Secretary Thompson has announced the purchase from pharmaceutical company



Emeryville, Bio Tech Earnings Timeline ... See Bay Area Earnings timeline, World Earnings timeline Top ^
2005 Oct.18 Problems Cause Chiron To Miss Earnings  Chiron Corp. won't ship as many flu shots as it initially had hoped Sep.7 Chiron shares head upward  Investors hope that Novartis will boost a $4.5 billion purchase offer that the biotechnology firm turned down



Emeryville, Bio Tech IPO Timeline ... See Bay Area IPO timeline, World IPO timeline Top ^
2010 Sep.28 Amyris IPO price holds steady
  Amyris Biotechnologies, an startup that uses genetically modified yeast to produce biofuel, sold shares for the first time on the Nasdaq, closing at $16.50